Healthcare provider profile · identity verified

Mythily Meda, M.D.

Internal Medicine · CHELMSFORD, MA · NPI 1649469925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	742	199
Amlodipine Besylate	Amlodipine Besylate	518	126
Lisinopril	Lisinopril	482	126
Levothyroxine Sodium	Levothyroxine Sodium	330	86
Simvastatin	Simvastatin	275	75
Omeprazole	Omeprazole	274	77
Losartan Potassium	Losartan Potassium	216	58
Gabapentin	Gabapentin	198	50
Hydrochlorothiazide	Hydrochlorothiazide	192	55
Pravastatin Sodium	Pravastatin Sodium	181	40
Metoprolol Succinate	Metoprolol Succinate	173	46
Metformin Hcl Er	Metformin Hcl	167	51
Pantoprazole Sodium	Pantoprazole Sodium	154	43
Atenolol	Atenolol	147	46
Famotidine	Famotidine	136	42
Ozempic	Semaglutide	122	23
Lorazepam	Lorazepam	120	32
Sertraline Hcl	Sertraline Hcl	115	36
Albuterol Sulfate Hfa	Albuterol Sulfate	102	53
Trazodone Hcl	Trazodone Hcl	97	29
Furosemide	Furosemide	96	31
Metformin Hcl	Metformin Hcl	96	28
Fluticasone Propionate	Fluticasone Propionate	94	49
Rosuvastatin Calcium	Rosuvastatin Calcium	94	28
Eliquis	Apixaban	90	20
Citalopram Hbr	Citalopram Hydrobromide	88	27
Clonazepam	Clonazepam	84	12
Tamsulosin Hcl	Tamsulosin Hcl	76	18
Glimepiride	Glimepiride	70	17
Mirtazapine	Mirtazapine	67	22
Metoprolol Tartrate	Metoprolol Tartrate	65	18
Allopurinol	Allopurinol	57	17
Januvia	Sitagliptin Phosphate	56	13
Fluoxetine Hcl	Fluoxetine Hcl	53	11
Glipizide	Glipizide	52	12
Ventolin Hfa	Albuterol Sulfate	52	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	13
Oxybutynin Chloride Er	Oxybutynin Chloride	51	11
Labetalol Hcl	Labetalol Hcl	47	suppressed
Nystatin	Nystatin	45	27
Clopidogrel	Clopidogrel Bisulfate	44	13
Montelukast Sodium	Montelukast Sodium	44	14
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Duloxetine Hcl	Duloxetine Hcl	42	11
Oxycodone Hcl	Oxycodone Hcl	42	13
Enalapril Maleate	Enalapril Maleate	41	suppressed
Torsemide	Torsemide	41	13
Synthroid	Levothyroxine Sodium	40	suppressed
Finasteride	Finasteride	39	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	15
Diazepam	Diazepam	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Glipizide Er	Glipizide	36	suppressed
Azelastine Hcl	Azelastine Hcl	34	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	30	suppressed
Potassium Chloride	Potassium Chloride	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Baclofen	Baclofen	28	suppressed
Lidocaine	Lidocaine	24	suppressed
Naproxen	Naproxen	24	13
Doxycycline Monohydrate	Doxycycline Monohydrate	23	23
Sucralfate	Sucralfate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Lactulose	Lactulose	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	11
Mounjaro	Tirzepatide	21	suppressed
Estradiol	Estradiol	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Xifaxan	Rifaximin	16	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Pregabalin	Pregabalin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	12	12
Fenofibrate	Fenofibrate,micronized	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error